IKTOS

SECTOR : TechBio
ENTRY DATE : 2022
BUSINESS: Venture Capital
WEB : https://iktos.ai/

Iktos is an innovative company specializing in the development of artificial intelligence (AI) solutions applied to chemical research, more specifically medicinal chemistry and new drug design. The use of Iktos technology platform enables major productivity gains in upstream pharmaceutical R&D.

Iktos technology is built upon the latest developments in deep learning algorithms, for de novo design and AI-driven synthesis planning. Founded in 2016, it has a portfolio of 50 plus real world projects either completed or ongoing. Its customizable technology offers multiple proprietary algorithms to clients, including large/medium pharma, biotech companies and research institutes globally.